Patient-derived xenografts of non small cell lung cancer: Resurgence of an old model for investigation of modern concepts of tailored therapy and cancer stem cells

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Moro, Massimo ^a   Bertolini, Giulia ^a   Tortoreto, Monica ^a   Pastorino, Ugo ^a   Sozzi, Gabriella ^a   Roz, Luca ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER MODEL; CANCER STEM CELL; EXPERIMENTAL MOUSE; HUMAN; LUNG NON SMALL CELL CANCER; NONHUMAN; TRANSGENIC ORGANISM; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; ANIMAL; DRUG SCREENING; LUNG TUMOR; METHODOLOGY; MOUSE; PATHOLOGY; PERSONALIZED MEDICINE; REVIEW;

MURINAE; MUS;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; INDIVIDUALIZED MEDICINE; LUNG NEOPLASMS; MICE; NEOPLASTIC STEM CELLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84861017334     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/568567     Document Type: Article

References (64)

1. Decaudin D., Primary human tumor xenografted models (tumorgrafts) for good management of patients with cancer Anti-Cancer Drugs 2011 22 9 827 841
2. Venkatesh S., Lipper R. A., Role of the development scientist in compound lead selection and optimization Journal of Pharmaceutical Sciences 2000 89 2 145 154 (Pubitemid 30120795)
3. Shoemaker R. H., The NCI60 human tumour cell line anticancer drug screen Nature Reviews Cancer 2006 6 10 813 823 (Pubitemid 44450469)
4. Burchill S. A., What do, can and should we learn from models to evaluate potential anticancer agents? Future Oncology 2006 2 2 201 211
5. Carter C. A., Chen C., Brink C., Vincent P., Maxuitenko Y. Y., Gilbert K. S., Waud W. R., Zhang X., Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma Cancer Chemotherapy and Pharmacology 2007 59 2 183 195 (Pubitemid 44885148)
6. Voskoglou-Nomikos T., Pater J. L., Seymour L., Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models Clinical Cancer Research 2003 9 11 4227 4239 (Pubitemid 37204044)
7. Chow L. Q. M., Eckhardt S. G., Sunitinib: from rational design to clinical efficacy Journal of Clinical Oncology 2007 25 7 884 896 (Pubitemid 350002890)
8. Fogh J., Giovanella B. C., The Nude Mouse in Experimental and Clinical Research 1978 Academic Press
9. Castrop H., Genetically modified mice-successes and failures of a widely used technology Pflugers Archiv European Journal of Physiology 2010 459 4 557 567
10. Wells D. J., Genetically modified animals and pharmacological research Handbook of Experimental Pharmacology 2010 199 213 226
11. Sosa M. A. G., De Gasperi R., Elder G. A., Animal transgenesis: an overview Brain Structure and Function 2010 214 2-3 91 109
12. Gordon J. W., Scangos G. A., Plotkin D. J., Genetic transformation of mouse embryos by microinjection of purified DNA Proceedings of the National Academy of Sciences of the United States of America 1980 77 12 7380 7384 (Pubitemid 11131133)
13. Thomas K. R., Capecchi M. R., Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells Cell 1987 51 3 503 512
14. Lin J. H., Applications and limitations of genetically modified mouse models in drug discovery and development Current Drug Metabolism 2008 9 5 419 438 (Pubitemid 352025196)
15. Bolon B., Genetically engineered animals in drug discovery and development: a maturing resource for toxicologic research Basic and Clinical Pharmacology and Toxicology 2004 95 4 154 161 (Pubitemid 39472959)
16. Clarke R., Animal models of breast cancer: experimental design and their use in nutrition and psychosocial research Breast Cancer Research and Treatment 1997 46 2-3 117 133 (Pubitemid 28029516)
17. Peterson J. K., Houghton P. J., Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development European Journal of Cancer 2004 40 6 837 844 (Pubitemid 38519762)
18. Firestone B., The challenge of selecting the right in vivo oncology pharmacology model Current Opinion in Pharmacology 2010 10 4 391 396
19. Rygaard J., Povlsen C. O., Heterotransplantation of a human malignant tumour to Nude mice Acta Pathologica et Microbiologica Scandinavica 1969 77 4 758 760
20. Giovanella B. C., Yim S. O., Stehlin J. S., Williams L. J., Development of invasive tumors in the nude mouse after injection of cultured human melanoma cells Journal of the National Cancer Institute 1972 48 5 1531 1533
21. Giovanella B. C., Vardeman D. M., Williams L. J., Taylor D. J., De Ipolyi P. D., Greeff P. J., Stehlin J. S., Ullrich A., Cailleau R., Slamon D. J., Gary H. E., Heterotransplantation of human breast carcinomas in nude mice. Correlation between successful heterotransplants, poor prognosis and amplification of the HER-2/neu oncogene International Journal of Cancer 1991 47 1 66 71
22. Daniel V. C., Marchionni L., Hierman J. S., Rhodes J. T., Devereux W. L., Rudin C. M., Yung R., Parmigiani G., Dorsch M., Peacock C. D., Watkins D. N., A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro Cancer Research 2009 69 8 3364 3373
23. Kerbel R. S., Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved Cancer biology therapy 2003 2 4 S134 S139
24. Johnson J. I., Decker S., Zaharevitz D., Rubinstein L. V., Venditti J. M., Schepartz S., Kalyandrug S., Christian M., Arbuck S., Hollingshead M., Sausville E. A., Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials British Journal of Cancer 2001 84 10 1424 1431 (Pubitemid 32522115)
25. Scholz C. C., Berger D. P., Winterhalter B. R., Henss H., Fiebig H. H., Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenografts European Journal of Cancer 1990 26 8 901 905
26. Hidalgo M., Bruckheimer E., Rajeshkumar N. V., Garrido-Laguna I., De Oliveira E., Rubio-Viqueira B., Strawn S., Wick M. J., Martell J., Sidransky D., A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer Molecular Cancer Therapeutics 2011 10 8 1311 1316
27. Bertotti A., Migliardi G., Galimi F., A molecularly annotated platform of patient-derived xenografts (Xenopatient) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer Cancer Discovery 2011 1 6 508 523
28. Krumbach R., Schler J., Hofmann M., Giesemann T., Fiebig H. -H., Beckers T., Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance European Journal of Cancer 2011 47 8 1231 1243
29. Sun S., Schiller J. H., Gazdar A. F., Lung cancer in never smokersa different disease Nature Reviews Cancer 2007 7 10 778 790 (Pubitemid 47463669)
30. Spira A., Beane J., Shah V., Liu G., Schembri F., Yang X., Palma J., Brody J. S., Effects of cigarette smoke on the human airway epithelial cell transcriptome Proceedings of the National Academy of Sciences of the United States of America 2004 101 27 10143 10148 (Pubitemid 38891209)
31. Plowman J., Dykes D. J., Hollingshead M., Simpson-Herren L., Alley M. C., Teicher B., Human tumor xenograft models in NCI drug development Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials and Approval 1997 Totowa, NJ Humana Press 101 125
32. John T., Kohler D., Pintilie M., Yanagawa N., Pham N. -A., Li M., Panchal D., Hui F., Meng F., Shepherd F. A., Tsao M. -S., The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer Clinical Cancer Research 2011 17 1 134 141
33. Bertolini G., Roz L., Perego P., Tortoreto M., Fontanella E., Gatti L., Pratesi G., Fabbri A., Andriani F., Tinelli S., Roz E., Caserini R., Lo Vullo S., Camerini T., Mariani L., Delia D., Calabr E., Pastorino U., Sozzi G., Highly tumorigenic lung cancer CD133 + cells display stem-like features and are spared by cisplatin treatment Proceedings of the National Academy of Sciences of the United States of America 2009 106 38 16281 16286
34. Fichtner I., Rolff J., Soong R., Hoffmann J., Hammer S., Sommer A., Becker M., Merk J., Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers Clinical Cancer Research 2008 14 20 6456 6468
35. Hammer S., Sommer A., Fichtner I., Becker M., Rolff J., Merk J., Klar U., Hoffmann J., Comparative profiling of the novel epothilone, sagopilone, in xenografts derived from primary non-small cell lung cancer Clinical Cancer Research 2010 16 5 1452 1465
36. Dong X., Guan J., English J. C., Flint J., Yee J., Evans K., Murray N., MacAulay C., Ng R. T., Gout P. W., Lam W. L., Laskin J., Ling V., Lam S., Wang Y., Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy Clinical Cancer Research 2010 16 5 1442 1451
37. Marangoni E., Vincent-Salomon A., Auger N., Degeorges A., Assayag F., De Cremoux P., De Plater L., Guyader C., De Pinieux G., Judde J. G., Rebucci M., Tran-Perennou C., Sastre-Garau X., Sigal-Zafrani B., Delattre O., Diéras V., Poupon M. F., A new model of patient tumor-derived breast cancer xenografts for preclinical assays Clinical Cancer Research 2007 13 13 3989 3998 (Pubitemid 47037607)
38. De Plater L., Laugé A., Guyader C., Poupon M. F., Assayag F., De Cremoux P., Vincent-Salomon A., Stoppa-Lyonnet D., Sigal-Zafrani B., Fontaine J. J., Brough R., Lord C. J., Ashworth A., Cottu P., Decaudin D., Marangoni E., Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation British Journal of Cancer 2010 103 8 1192 1200
39. Simpson-Abelson M. R., Sonnenberg G. F., Takita H., Yokota S. J., Conway T. F., Kelleher R. J., Shultz L. D., Barcos M., Bankert R. B., Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2R null Mice Journal of Immunology 2008 180 10 7009 7018
40. Reya T., Morrison S. J., Clarke M. F., Weissman I. L., Stem cells, cancer, and cancer stem cells Nature 2001 414 6859 105 111 (Pubitemid 33041634)
41. Pardal R., Clarke M. F., Morrison S. J., Applying the principles of stem-cell biology to cancer Nature Reviews Cancer 2003 3 12 895 902 (Pubitemid 37500174)
42. Clarke M. F., Self-renewal and solid-tumor stem cells Biology of Blood and Marrow Transplantation 2005 11 2 14 16 (Pubitemid 40186218)
43. Clarke M. F., Dick J. E., Dirks P. B., Eaves C. J., Jamieson C. H. M., Jones D. L., Visvader J., Weissman I. L., Wahl G. M., Cancer stem cellsperspectives on current status and future directions: AACR workshop on cancer stem cells Cancer Research 2006 66 19 9339 9344 (Pubitemid 44623625)
44. Bonnet D., Dick J. E., Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nature Medicine 1997 3 7 730 737 (Pubitemid 27298715)
45. Singh S. K., Clarke I. D., Terasaki M., Bonn V. E., Hawkins C., Squire J., Dirks P. B., Identification of a cancer stem cell in human brain tumors Cancer Research 2003 63 18 5821 5828 (Pubitemid 37187480)
46. Hemmati H. D., Nakano I., Lazareff J. A., Masterman-Smith M., Geschwind D. H., Bronner-Fraser M., Kornblum H. I., Cancerous stem cells can arise from pediatric brain tumors Proceedings of the National Academy of Sciences of the United States of America 2003 100 25 15178 15183 (Pubitemid 37518036)
47. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A., Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma Cancer Research 2004 64 19 7011 7021 (Pubitemid 39331011)
48. Fang D., Nguyen T. K., Leishear K., Finko R., Kulp A. N., Hotz S., Van Belle P. A., Xu X., Elder D. E., Herlyn M., A tumorigenic subpopulation with stem cell properties in melanomas Cancer Research 2005 65 20 9328 9337 (Pubitemid 41508000)
49. Schatton T., Murphy G. F., Frank N. Y., Yamaura K., Waaga-Gasser A. M., Gasser M., Zhan Q., Jordan S., Duncan L. M., Weishaupt C., Fuhlbrigge R. C., Kupper T. S., Sayegh M. H., Frank M. H., Identification of cells initiating human melanomas Nature 2008 451 7176 345 349
50. Al-Hajj M., Wicha M. S., Benito-Hernandez A., Morrison S. J., Clarke M. F., Prospective identification of tumorigenic breast cancer cells Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 3983 3988 (Pubitemid 36418143)
51. Bapat S. A., Mali A. M., Koppikar C. B., Kurrey N. K., Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer Cancer Research 2005 65 8 3025 3029 (Pubitemid 40524578)
52. Collins A. T., Berry P. A., Hyde C., Stower M. J., Maitland N. J., Prospective identification of tumorigenic prostate cancer stem cells Cancer Research 2005 65 23 10946 10951 (Pubitemid 41713363)
53. Ricci-Vitiani L., Lombardi D. G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R., Identification and expansion of human colon-cancer-initiating cells Nature 2007 445 7123 111 115 (Pubitemid 46067311)
54. O'Brien C. A., Pollett A., Gallinger S., Dick J. E., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 2007 445 7123 106 110 (Pubitemid 46067310)
55. Dalerba P., Dylla S. J., Park I. K., Liu R., Wang X., Cho R. W., Hoey T., Gurney A., Huang E. H., Simeone D. M., Shelton A. A., Parmiani G., Castelli C., Clarke M. F., Phenotypic characterization of human colorectal cancer stem cells Proceedings of the National Academy of Sciences of the United States of America 2007 104 24 10158 10163 (Pubitemid 47175279)
56. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., Conticello C., Ruco L., Peschle C., De Maria R., Identification and expansion of the tumorigenic lung cancer stem cell population Cell Death and Differentiation 2008 15 3 504 514 (Pubitemid 351267301)
57. Bertolini G., Gatti L., Roz L., The stem of chemoresistance Cell Cycle 2010 9 4 628 629
58. Jimeno A., Feldmann G., Surez-Gauthier A., Rasheed Z., Solomon A., Zou G. -M., Rubio-Viqueira B., Garca-Garca E., Lpez-Ros F., Matsui W., Maitra A., Hidalgo M., A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development Molecular Cancer Therapeutics 2009 8 2 310 314
59. Hoey T., Yen W. C., Axelrod F., Basi J., Donigian L., Dylla S., Fitch-Bruhns M., Lazetic S., Park I. K., Sato A., Satyal S., Wang X., Clarke M. F., Lewicki J., Gurney A., DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency Cell Stem Cell 2009 5 2 168 177
60. Ginestier C., Liu S., Diebel M. E., Korkaya H., Luo M., Brown M., Wicinski J., Cabaud O., Charafe-Jauffret E., Birnbaum D., Guan J. L., Dontu G., Wicha M. S., CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts Journal of Clinical Investigation 2010 120 2 485 497
61. Dylla S. J., Beviglia L., Park I. K., Chartier C., Raval J., Ngan L., Pickell K., Aguilar J., Lazetic S., Smith-Berdan S., Clarke M. F., Hoey T., Lewicki J., Gurney A. L., Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy PLoS One 2008 3 6
62. Rasheed Z. A., Yang J., Wang Q., Kowalski J., Freed I., Murter C., Hong S. M., Koorstra J. B., Rajeshkumar N. V., He X., Goggins M., Iacobuzio-Donahue C., Berman D. M., Laheru D., Jimeno A., Hidalgo M., Maitra A., Matsui W., Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma Journal of the National Cancer Institute 2010 102 5 340 351
63. Kim M. P., Fleming J. B., Wang H., Abbruzzese J. L., Choi W., Kopetz S., McConkey D. J., Evans D. B., Gallick G. E., ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma PLoS One 2011 6 6
64. Workman P., Aboagye E. O., Balkwill F., Balmain A., Bruder G., Chaplin D. J., Double J. A., Everitt J., Farningham D. A. H., Glennie M. J., Kelland L. R., Robinson V., Stratford I. J., Tozer G. M., Watson S., Wedge S. R., Eccles S. A., Navaratnam V., Ryder S., Guidelines for the welfare and use of animals in cancer research British Journal of Cancer 2010 102 11 1555 1577